The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology.Video above: Weight-loss ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

University of Pennsylvania and Syracuse University scientists have discovered that a hindbrain-derived peptide, octadecaneuropeptide (ODN), can suppress appetite and improve glucose regulation without ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

PepsiCo, Inc. (NASDAQ: PEP) is one of the stocks that Jim Cramer recently commented on. During the episode, Cramer noted that ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

In this week’s Kern Cares, Dr. Hashimoto from BFMG joined host Kait Hill to unpack one of today’s most talked-about health ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.